- Home
- TRSG vs ELEV Comparison
TRSG vs ELEV Comparison
Compare TRSG & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- ELEV
- Stock Information
- Founded
- TRSG 1996
- ELEV 2019
- Country
- TRSG Singapore
- ELEV United States
- Employees
- TRSG N/A
- ELEV N/A
- Industry
- TRSG
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- TRSG
- ELEV Health Care
- Exchange
- TRSG NYSE
- ELEV Nasdaq
- Market Cap
- TRSG 25.8M
- ELEV 22.8M
- IPO Year
- TRSG 2024
- ELEV 2021
- Fundamental
- Price
- TRSG $1.63
- ELEV $0.38
- Analyst Decision
- TRSG
- ELEV Hold
- Analyst Count
- TRSG 0
- ELEV 6
- Target Price
- TRSG N/A
- ELEV $1.77
- AVG Volume (30 Days)
- TRSG 8.2K
- ELEV 2.0M
- Earning Date
- TRSG 05-14-2025
- ELEV 08-05-2025
- Dividend Yield
- TRSG N/A
- ELEV N/A
- EPS Growth
- TRSG N/A
- ELEV N/A
- EPS
- TRSG N/A
- ELEV N/A
- Revenue
- TRSG $12,810,249.00
- ELEV N/A
- Revenue This Year
- TRSG N/A
- ELEV N/A
- Revenue Next Year
- TRSG N/A
- ELEV N/A
- P/E Ratio
- TRSG N/A
- ELEV N/A
- Revenue Growth
- TRSG N/A
- ELEV N/A
- 52 Week Low
- TRSG $1.00
- ELEV $0.22
- 52 Week High
- TRSG $4.57
- ELEV $3.28
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- ELEV 62.35
- Support Level
- TRSG N/A
- ELEV $0.38
- Resistance Level
- TRSG N/A
- ELEV $0.39
- Average True Range (ATR)
- TRSG 0.00
- ELEV 0.01
- MACD
- TRSG 0.00
- ELEV 0.00
- Stochastic Oscillator
- TRSG 0.00
- ELEV 85.00
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.